Status:
TERMINATED
Patients With NMDA Biomarker Data Following Cardiac Surgery
Lead Sponsor:
Children's Healthcare of Atlanta
Conditions:
Congenital Disorders
Eligibility:
All Genders
Up to 18 years
Brief Summary
The purpose of this current retrospective study is to perform follow-up analysis on the 22 children from the study # 621-2004 It is important to examine whether an elevated biomarker of brain ischemia...
Detailed Description
The N-Methyl-D-Aspartate (NMDA) receptor is unique to the brain. With brain injury or ischemia, fragments of the NMDA receptor (NR2) break off and appear in the bloodstream. These NR2 fragments genera...
Eligibility Criteria
Inclusion
- participated in previous 621-2004 blood marker study for infants and children having open-heart surgery with cardiopulmonary bypass with or without hypothermic circulatory arrest
Exclusion
- Those who do not meet inclusion criteria
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
July 1 2006
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00366886
End Date
July 1 2006
Last Update
June 13 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322